Democratizing hedge fund level analysis tools for everyone
| Name | Diagnos Laboratorium Utama Tbk. |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Providers |
| Code | F1 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Bundamedik | 41.2 | 41.2 |
| PT. Bunda Investama Indonesia | 38.8 | 38.8 |
| Public < 5% | 20.0 | 20.0 |
| Source | 2022 | 2021 |
|---|---|---|
| DGNS | F1 | Doctor Referrals |
| DGNS | F1 | Corporate Clients |
| DGNS | F1 | Walk in Customers |
| DGNS | F1 | Others |
| Region | 2022 | 2021 |
|---|---|---|
| DGNS | F1 | Indonesia |
| DGNS | F1 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.51 | # 6 / 22 |
| EV_EBITDA | 30.04 | # 16 / 22 |
| PER | -69.85 | --- / 22 |
| PBV | 1.23 | # 4 / 22 |
| DER | 0.58 | # 13 / 22 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -2.238 | --- / 22 |
| ROA % | -1.16 | --- / 22 |
| ROE % | -1.83 | --- / 22 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2021 | 9.6 | 1.2 |
| Timeframe | Performance |
|---|---|
| 1W % | -5.0 |
| 1Mo % | -2.6 |
| 3Mo % | 33.8 |
| 1Yr % | -13.6 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| SRAJ | -1,706.31 | 201.94 T | 206.18 T | 2,500 B | 479 B | -118 B |
| MIKA | 25.12 | 34.07 T | 33.23 T | 5,307 B | 2,049 B | 1,356 B |
| SILO | 32.15 | 32.65 T | 36.15 T | 12,567 B | 2,702 B | 1,015 B |
| CARE | 8,388.89 | 25.10 T | 25.56 T | 314 B | 67 B | 3 B |
| HEAL | 44.60 | 21.13 T | 24.85 T | 7,051 B | 1,874 B | 475 B |
| PRAY | 53.05 | 11.52 T | 13.07 T | 2,332 B | 510 B | 218 B |